profile picture

Farheen Shaikh

Zydus Therapeutics Inc.

polycystic ovary syndrome

non-alcoholic fatty liver disease

proton-density fat-fraction

1

presentations

SHORT BIO

• Dynamic management professional offering more than 14 years of experience in Clinical Research and Global Clinical Trial Management primarily with New Chemical Entities (NCEs) developed under IND for USA in the areas of Hepatology including unmet medical condition as Non-alcoholic Steatohepatitis (NASH), , Nonalcoholic Fatty Liver Diseases (NAFLD) with Polycystic Ovarian Syndrome (PCOS), NALFD in post-transplant patients, and a rare disease condition as Primary Biliary Cholangitis (PBC • Strong Medical background along with expertise in Clinical Research and in-depth knowledge and skills in the application of ICH Good Clinical Practice (GCP) and regulatory requirements for India, US FDA, EMA etc. • Excellent trainer and speaker in regional and national workshops; GCP trainer for sites and ethics committees

Presentations

Evidences VII – Ongoing Proof Of Concept Study Of Saroglitazar In Treatment Of NaFlD In Women With PCOS

Farheen Shaikh

Stay up to date with the latest Underline news!

Select topic of interest (you can select more than one)

PRESENTATIONS

  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2025 Underline - All rights reserved